Prognostic Value of N-Terminal Pro-Type-B Natriuretic Peptide and Doppler Left Ventricular Diastolic Variables in Patients With Chronic Systolic Heart Failure Stabilized by Therapy

American Journal of Cardiology

Volumn 102, Issue 4, 2008, Pages 463-468

  Dini, Frank Lloyd ^a   Conti, Umberto ^a   Fontanive, Paolo ^a   Andreini, Diana ^a   Panicucci, Erica ^b   De Tommasi, Salvatore Mario ^a  

^a SANTA CHIARA HOSPITAL   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CHI SQUARE TEST; CONTROLLED STUDY; DEFIBRILLATOR; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SYSTOLIC HEART FAILURE; VELOCITY;

AGED; CHRONIC DISEASE; DIASTOLE; FEMALE; HEART FAILURE; HEART SEPTUM; HUMANS; MALE; MITRAL VALVE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; SYSTOLE; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR DYSFUNCTION, LEFT;

EID: 50949134023     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.03.083     Document Type: Article

References (27)

1. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 84-88
2. Chakko S., Woska D., Martinez H., de Marchena E., Futterman L., Kessler K.M., and Myerberg R.J. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 90 (1991) 353-359
3. Johnson W., Omland T., Hall C., Lucas C., Myking O.L., Collins C., Pfeffer M., Rouleau J.L., and Stevenson L.W. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 39 (2002) 1623-1629
4. Gardner R.S., Ozalp E., Murday A.J., Robb S.D., and McDonagh T.A. N-Terminal pro-brain natriuretic peptide. A gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743
5. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., and Ferreira A. N-Terminal pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
6. Nishimura R.A., and Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is clinician's Rosetta stone. J Am Coll Cardiol 30 (1997) 8-18
7. Hunt S.A. American College of Cardiology; American Heart Association Task Force on Practice Guidelines. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46 (2005) 1-82
8. Lang R.M., Bierig M., and Deveraux R.B. Recommendations for chamber quantification. Eur J Echocardiogr 7 (2006) 79-108
9. Appleton C.P., Hatle L.K., and Popp R.L. Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 12 (1988) 426-440
10. Whalley G.A., Gamble G.D., Dini F.L., Klein A.L., Moller J.E., Quintana M., Yu C.M., Doughty R.N., and Meta-Analysis Research Group in Echocardiography (MeRGE) Collaborators. Individual patient meta-analyses of restrictive diastolic filling pattern and mortality in patients post acute myocardial infarction and in patients with chronic heart failure. Int J Cardiol 122 (2007) 207-215
11. Throughton R.W., Frampton C.M., Yandle T.G., Espiner E.A., Nicholis M.G., and Richards A.M. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide concentrations. Lancet 355 (2000) 1126-1130
12. Cohn J.N., Johnson G.R., Shabetai R., Loeb H., Tristani F., Rector T., Smith R., and Fletcher R. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87 suppl VI (1993) S5-S15
13. Benedict C., Johnstone D.E., Weiner D.H., Bourassa M.G., Bittner V., Kay R., Kirlin P., Greenberg B., Kohn R.M., Nicklas J.M., et al. Relation of neurohormonal activation to clinical variables and degree of ventricular dysfunction: a report from the Registry of Studies of Left Ventricular Dysfunction. SOLVD Investigators. J Am Coll Cardiol 23 (1994) 1410-1420
14. Steimle A.E., Stevenson L.W., Kelimsky-Fallick C., Fonarow G.C., Hamilton M.A., Moriguchi J.D., Kartashov A., and Tillish J.H. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure. Circulation 96 (1997) 1165-1172
15. Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C.S., Kubo S.H., Rudin-Toretsky E., and Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with or without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82 (1990) 1724-1729
16. Lucas C., Johnson W., Hamilton M.A., Fonarow G.C., Woo M.A., Flavell C.M., Creaser J.A., and Stevenson L.W. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140 (2000) 824-826
17. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., Tunstall-Pedoe H., McMurray J.J., and Dargie H.J. Biochemical detection of left ventricular systolic dysfunction. Lancet 351 (1998) 9-13
18. Cowie M.R., Struthers A.D., Wood D.A., Coats A.J., Thompson S.G., Poole-Wilson P.A., and Sutton S.G. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 350 (1997) 1349-1353
19. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Mabuchi N., Hayashi M., Ohnishi M., Sawaki M., Fujji M., Horie H., Sugimoto Y., and Kinoshita M. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 20 (1999) 1799-1807
20. Xie G.Y., Berk M.R., Smith M.D., Gurley J.C., and DeMaria A.N. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol 24 (1994) 132-139
21. Wang M., Yip G.W.K., Wang A.Y.M., Zhang Y., Ho P.Y., Tse M.K., Lam P.K.W., and Sanderson J.E. Peak early diastolic annular velocity by tissue Doppler adds independent and incremental prognostic value. J Am Coll Cardiol 41 (2003) 820-826
22. Hillis G.S., Moller J.E., Pellikka P., Gersh B.J., Wright R.S., Ommen S.R., Reeder G.S., and Oh J.K. Non invasive estimation of left ventricular filling pressure by E/e′ is a powerful predictor of survival after acute myocardial infarction. J Am Coll Cardiol 43 (2004) 360-367
23. Gackowski A., Isnard R., Golmard J.L., Pousset F., Carayon A., Montalescot G., Hulot J.S., Thomas D., Piwowarska W., and Komajda M. Comparison of echocardiography and plasma B-type natriuretic peptide for monitoring the response to treatment in acute heart failure. Eur Heart J 25 (2004) 1788-1796
24. Dokainish H., Zoghbi W.A., Lakkis N.M., Ambriz E., Patel R., Quinones M.A., and Nagueh S.F. Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 45 (2004) 1223-1226
25. Bruch C., Rothenburger M., Gotzmann M., Sindermann J., Scheld H.H., Breithardt G., and Wichter T. Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. J Am Soc Echocardiogr 19 (2006) 522-528
26. Redfield M.M., Rodeheffer R.J., Jacobsen S.J., Mahoney D.W., Bailey K.R., and Burnett Jr. J.C. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40 (2002) 976-982
27. Luchner A., Hengstenberg C., Lowel H., Riegger G.A.J., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers. Direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 46 (2005) 118-123